Código QR (código de barras bidimensional)

Baseline plasma IL-18 may predict simvastatin treatment response in patients with ARDS: a secondary analysis of the HARP-2 randomised clinical trial

Abstract Background Interleukin (IL)-18 is a marker of inflammasome activation, and high baseline plasma IL-18 is associated with increased mortality in patients with sepsis-induced ARDS. The aim of this analysis was to determine if simvastatin was associated with benefit in patients with ARDS and h...

Fuld beskrivelse

Na minha lista:
Principais autores: Andrew James Boyle, Peter Ferris, Ian Bradbury, John Conlon, Manu Shankar-Hari, Angela J. Rogers, Cecilia M. O’Kane, Daniel F. McAuley
Format: Artigo
Sprog:Inglês
Udgivet: BMC 2022-06-01
Serier:Critical Care
Fag:
Acute respiratory distress syndrome
Simvastatin
Inflammasome
Interleukin-18
Personalised medicine
Online adgang:https://doi.org/10.1186/s13054-022-04025-w
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker